COMT Val108/158Met genotype affects the mu-opioid receptor system in the human brain: Evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression
暂无分享,去创建一个
Stefan Platzer | Achim Berthele | Henning Boecker | Bastian Conrad | Thomas R. Tölle | Burkard Jochim | Andreas Buettner | Matthias Riemenschneider | H. Boecker | B. Conrad | M. Riemenschneider | T. Tölle | A. Berthele | S. Platzer | A. Buettner | Burkard Jochim
[1] M. Kreek,et al. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. , 1994, Neuroreport.
[2] W Zieglgänsberger,et al. [3h]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brain , 2003, Neuroscience.
[3] A. Parent,et al. Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys , 1994, Neuroreport.
[4] J. F. Chen,et al. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum , 1993, Neuroscience.
[5] Susan R. George,et al. Met-enkephalin concentrations in striatum respond reciprocally to alterations in dopamine neurotransmission , 1987, Peptides.
[6] C D Marsden,et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. , 1995, Brain research. Molecular brain research.
[7] P. Jenner,et al. Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets , 2002, Neuroscience.
[8] J. P. Schwartz,et al. Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Straub,et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Jenner,et al. Chronicl-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat , 1995, Neuroscience.
[11] A. Malhotra,et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.
[12] T. Di Paolo,et al. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy. , 1997, Brain research. Molecular brain research.
[13] M. Egan,et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.
[14] Anat Biegon,et al. Regionally selective increases in μ opioid receptor density in the brains of suicide victims , 1990, Brain Research.
[15] C. Gerfen,et al. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior , 1998, Experimental Brain Research.
[16] B. Kolachana,et al. Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human Brain , 2003, The Journal of Neuroscience.
[17] Kenneth K Kidd,et al. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.
[18] B. Bloch,et al. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum , 2000, The Journal of comparative neurology.
[19] D. Selley,et al. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Lieberman,et al. Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia , 2002, Biological Psychiatry.
[21] J. Zubieta,et al. Brain opioid receptor measurements by positron emission tomography in normal cycling women: relationship to luteinizing hormone pulsatility and gonadal steroid hormones. , 1998, The Journal of clinical endocrinology and metabolism.
[22] E. G. Jones,et al. Distribution of tachykinin- and enkephalin-immunoreactive fibers in the human thalamus , 1989, Brain Research Reviews.
[23] Stefan Platzer,et al. Autoradiographic distribution of μ-, δ- and κ1-opioid stimulated [35S]guanylyl-5′-O-(γ-thio)-triphosphate binding in human frontal cortex and cerebellum , 2000, Neuroscience Letters.
[24] Joshua A. Bueller,et al. COMT val158met Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain Stressor , 2003, Science.
[25] Y. Hurd,et al. Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain , 1996, Neuroscience.
[26] J. Zubieta,et al. Gender and age influences on human brain mu-opioid receptor binding measured by PET. , 1999, The American journal of psychiatry.
[27] A. Craig,et al. Pain mechanisms: labeled lines versus convergence in central processing. , 2003, Annual review of neuroscience.
[28] R. Weinshilboum,et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.
[29] Jacob M. Hiller,et al. Laminar distribution of the multiple opioid receptors in the human cerebral cortex , 1996, Neurochemical Research.
[30] Eric J. Simon,et al. μ-, δ- and κ-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer’s disease patients , 2001, Brain Research.
[31] J. Daunais,et al. Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate , 2001, The Journal of comparative neurology.
[32] S. Ho,et al. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. , 1999, Molecular pharmacology.
[33] C. Gerfen,et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.
[34] R. Weinshilboum,et al. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes , 2004, Molecular Psychiatry.